Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report

BACKGROUND: Tumor necrosis factor antagonist inhibitors have transformed the approach to patients with severe autoimmune conditions, such as rheumatoid arthritis. Although the therapy can be highly effective, TNF-α inhibitors are associated with an increased risk of opportunistic infections. CASE PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Oca, Juan E., Villarreal Morales, Martha L., Nieves-Rodriguez, Aracelis, Martínez-Bonilla, Lemuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237312/
https://www.ncbi.nlm.nih.gov/pubmed/28086756
http://dx.doi.org/10.1186/s12879-016-2097-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237312/
https://www.ncbi.nlm.nih.gov/pubmed/28086756
http://dx.doi.org/10.1186/s12879-016-2097-7

Ejemplares similares